134 related articles for article (PubMed ID: 1986081)
1. Hematin therapy for the neurologic crisis of tyrosinemia.
Rank JM; Pascual-Leone A; Payne W; Glock M; Freese D; Sharp H; Bloomer JR
J Pediatr; 1991 Jan; 118(1):136-9. PubMed ID: 1986081
[No Abstract] [Full Text] [Related]
2. Liver transplantation in nine Spanish patients with tyrosinaemia type I.
Pérez-Cerdá C; Merinero B; Sanz P; Castro M; Gangoiti J; García MJ; Díaz M; Medina E; Ugarte M
J Inherit Metab Dis; 1995; 18(2):119-22. PubMed ID: 7564224
[No Abstract] [Full Text] [Related]
3. [Surgical and metabolic aspects of liver transplantation for tyrosinemia].
Bruneau N; St-Vil D; Luks FI; LaBerge JM; Bensoussan AL; Blanchard H
Ann Chir; 1993; 47(9):803-9. PubMed ID: 8141543
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
Christensen E; Jacobsen BB; Gregersen N; Hjeds H; Pedersen JB; Brandt NJ; Baekmark UB
Clin Chim Acta; 1981 Nov; 116(3):331-41. PubMed ID: 7296896
[TBL] [Abstract][Full Text] [Related]
5. [Tyrosinemia].
Salo MK
Duodecim; 1992; 108(9):841-3. PubMed ID: 1366298
[No Abstract] [Full Text] [Related]
6. Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.
Tuchman M; Freese DK; Sharp HL; Ramnaraine ML; Ascher N; Bloomer JR
J Pediatr; 1987 Mar; 110(3):399-403. PubMed ID: 3546650
[TBL] [Abstract][Full Text] [Related]
7. [Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I].
Barkaoui E; Debray D; Habès D; Ogier H; Bernard O
Arch Pediatr; 1999 May; 6(5):540-4. PubMed ID: 10370811
[TBL] [Abstract][Full Text] [Related]
8. Impaired synthesis of taurine in a patient with tyrosinemia type I during the oral L-methionine loading test.
Valík D; Klusácek D; Pintera J
Clin Chim Acta; 1992 Sep; 210(3):227-9. PubMed ID: 1468144
[No Abstract] [Full Text] [Related]
9. Succinylacetone and delta-aminolevulinic acid dehydratase in hereditary tyrosinemia: immunochemical study of the enzyme.
Sassa S; Fujita H; Kappas A
Pediatrics; 1990 Jul; 86(1):84-6. PubMed ID: 2359685
[TBL] [Abstract][Full Text] [Related]
10. Pathological case of the month. Hereditary tyrosinemia type I.
Barness L; Gilbert-Barness E
Am J Dis Child; 1992 Jun; 146(6):769-70. PubMed ID: 1595638
[No Abstract] [Full Text] [Related]
11. [Renal involvement in type I tyrosinemia].
Cochat P; Guibaud P; Baverel G
Arch Pediatr; 1994 Apr; 1(4):417-8. PubMed ID: 7842099
[No Abstract] [Full Text] [Related]
12. Liver transplantation for hereditary tyrosinemia--early transplantation following the patient's stabilization.
Sokal EM; Bustos R; Van Hoof F; Otte JB
Transplantation; 1992 Nov; 54(5):937-9. PubMed ID: 1440864
[No Abstract] [Full Text] [Related]
13. Tyrosinaemia type Ia without excess of urinary succinylacetone.
Biasucci G; Giuffré B; La Grutta S; Riva E
J Inherit Metab Dis; 1993; 16(6):1056-7. PubMed ID: 8127063
[No Abstract] [Full Text] [Related]
14. Cholestasis and hypermethioninemia during dietary management of hereditary tyrosinemia type 1.
Ameen VZ; Powell GK; Rassin DK
J Pediatr; 1986 Jun; 108(6):949-52. PubMed ID: 2872285
[No Abstract] [Full Text] [Related]
15. Liver transplantation in two children with tyrosinaemia type I: biochemical aspects.
Riudor E; Ribes A; Lloret J; Friden J; Holme E; Jakobs C; Martinez Ibanez V
J Inherit Metab Dis; 1991; 14(3):281-4. PubMed ID: 1770775
[No Abstract] [Full Text] [Related]
16. Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemia.
Berger R; Smit GP; Stoker-de Vries SA; Duran M; Ketting D; Wadman SK
Clin Chim Acta; 1981 Jul; 114(1):37-44. PubMed ID: 7249373
[TBL] [Abstract][Full Text] [Related]
17. Early liver transplantation is indicated for tyrosinemia type I.
Freese DK; Tuchman M; Schwarzenberg SJ; Sharp HL; Rank JM; Bloomer JR; Ascher NL; Payne WD
J Pediatr Gastroenterol Nutr; 1991 Jul; 13(1):10-5. PubMed ID: 1919940
[TBL] [Abstract][Full Text] [Related]
18. Hereditary tyrosinaemia type I: a long-term study of the relationship between the urinary excretions of succinylacetone and delta-aminolevulinic acid.
Schierbeek H; Beukeveld GJ; van Faassen H; van Spronsen FJ; Bijsterveld K; Venekamp-Hoolsema EE; Wolthers BG; Smit GP
J Inherit Metab Dis; 1993; 16(6):1034-40. PubMed ID: 8127053
[TBL] [Abstract][Full Text] [Related]
19. Nephropathy of tyrosinemia and its long-term outlook.
Paradis K; D'Angata ID
J Pediatr Gastroenterol Nutr; 1997 Jan; 24(1):113-4. PubMed ID: 9093996
[No Abstract] [Full Text] [Related]
20. Hereditary tyrosinemia of chronic course without rickets and renal tubular dysfunction.
Søvik O; Kvittingen EA; Steen-Johnsen J; Halvorsen S
Acta Paediatr Scand; 1990 Nov; 79(11):1063-8. PubMed ID: 2267924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
